Related Experiment Videos
"On-off" phenomena related to high plasma levodopa
British Medical Journal
|June 16, 1973
Summary
Parkinson's disease "on-off" phenomena may be toxic levodopa reactions, not absorption issues. High drug levels correlate with neurological decline, suggesting management should focus on stabilizing serum levodopa concentrations.
Area of Science:
- Neurology
- Pharmacology
Background:
- Parkinson's disease (PD) management often involves levodopa therapy.
- Patients with PD can experience unpredictable "on-off" fluctuations in motor control.
- The exact cause of these "on-off" phenomena remains a significant clinical challenge.
Purpose of the Study:
- To investigate the relationship between plasma levodopa concentrations and neurological deficits in a patient with Parkinson's disease experiencing "on-off" phenomena.
- To determine if "on-off" episodes are linked to drug absorption or toxicity.
Main Methods:
- A single patient with Parkinson's disease and "on-off" phenomena was studied.
- Plasma levodopa levels were monitored.
- Neurological status, specifically dysphonia (speech impairment), was assessed during "on-off" episodes through blind evaluations.
Main Results:
- Episodes of neurological deterioration, including dysphonia, were strongly associated with very high plasma levodopa concentrations.
- These high levodopa levels occurred shortly after drug ingestion.
- The findings suggest a correlation between peak levodopa levels and neurological impairment.
Conclusions:
- "On-off" phenomena in Parkinson's disease may represent toxic reactions to levodopa rather than inadequate drug intake or absorption.
- Clinical management should prioritize minimizing fluctuations in serum levodopa levels to mitigate these adverse events.